All News

    Cosibelimab Elicits Positive Tumor Response in Patients With Metastatic Skin Cancer Subtype

    January 25th 2022

    Patients with metastatic cutaneous squamous cell carcinoma achieved promising response rates after treatment with cosibelimab. If approved, drug developers are hoping to offer cosibelimab as a more affordable immunotherapy option for this patient population.

    For Better and for Worse: How the COVID-19 Pandemic Changed Cancer Care

    January 25th 2022

    The COVID-19 pandemic drastically impacted many facets of cancer care. Although some changes were detrimental, an expert from Johns Hopkins Medicine notes others actually improved accessibility to care.

    ‘Let’s Take the Stairs:’ How I Encouraged My Daughter to Get Exercise During Cancer Treatments

    January 25th 2022

    A mother of a breast cancer survivor explains how she and her daughter creatively incorporated exercise into her daughter’s daily routine to improve her physical and mental health during treatment.

    Keytruda Plus Mektovi and Avastin Associated With Survival Benefit in Metastatic Colon Cancer

    January 25th 2022

    A group of patients with microsatellite-stable, treatment-refractory metastatic colorectal cancer experienced responses to treatment with Keytruda plus Mektovi and Avastin.

    Blood Test Results May Identify Which Patients With CRC May Benefit From Post-Surgical Chemotherapy

    January 25th 2022

    The use of a ctDNA assay could help determine which patients with colorectal cancer may benefit most from chemotherapy after surgery.

    VHL-Related Kidney Cancer Survivor Reflects on Decades of Change for the Rare Condition

    January 24th 2022

    When Joseph Heisler was diagnosed with von Hippel-Lindau disease 30 years ago, there was hardly any information on the condition. Fast forward three decades, there is an FDA-approved drug and a handbook of information available in two languages.

    Kymriah Shows ‘Huge Potential’ for Patients With Heavily Pretreated, Relapsed Follicular Lymphoma

    January 24th 2022

    Kymriah may represent a more effective option than currently available treatments for patients with heavily pretreated follicular lymphoma, according to an expert from The University of Texas MD Anderson Cancer Center.

    Support From Beyond: How My Deceased Loved Ones Helped Me Navigate My Cancer Journey

    January 24th 2022

    A survivor of multiple cancers explains how “visits” from deceased friends and loved ones made her feel safe before undergoing treatments.

    Gut Microbiome Makeup May Help Predict Skin-Related Immunotherapy Side Effects in Patients With Gastric Cancer

    January 24th 2022

    Patients with gastric cancer who present with certain bacteria in their gut were found to be more likely to experience skin-related side effects from Opdivo treatment, research showed.

    Patients With Unresectable Liver Cancer May Have a ‘Promising and Tolerable’ Treatment Option With Combination Therapy

    January 24th 2022

    The use of a non-invasive procedure combined with Lenvima plus Tyvyt demonstrated safe and effective results in patients with liver cancer not eligible for surgical resection.

    Here’s to Appreciating Life and the Places You’ll Go, Despite Living With Cancer

    January 23rd 2022

    A woman living with metastatic breast cancer describes how the death of a friend’s grandmother reminded her of her own grandmother’s passing and the lessons she learned about life from it that she applies in her cancer journey.

    Lenvima May Offer Survival Benefit With Manageable Side Effects in Recurrent HCC After Liver Transplantation

    January 23rd 2022

    Researchers observed this benefit in recurrent HCC after liver transplantation, which represents a patient population often excluded from clinical trials due to potential organ rejection.

    As I Begin Another Year of Cancer Treatment, I Struggle Over Why I’m Still Here and Others Aren’t

    January 22nd 2022

    A patient with stage 4 ovarian cancer still receiving treatment six years after her first diagnosis explains that even though she’s exhausted from all her treatments and the related side effects, she knows many others don’t survive as long as she has.

    Frontline Lenvima Provided Survival Benefit for Patients With Liver Cancer

    January 22nd 2022

    Treating patients with liver cancer initially with Lenvima instead of the standard of care was associated with a survival benefit, according to recent research.

    Minimally Invasive Procedure Combined with Lenvima and Checkpoint Blockade Shows Promise in Unresectable Liver Cancer

    January 21st 2022

    The use of a minimally invasive procedure — known as trans-arterial chemoembolization — plus Lenvima and a PD-1 checkpoint blockade drug proved to be safe and efficacious in patients with unresectable advanced liver cancer.

    ‘Make an Impact and Seize the Day’ Says Cancer Survivor Who Launched Kindness Challenge

    January 21st 2022

    Lorelei Colbert was diagnosed with triple-negative breast cancer at 28 and used her experience to launch the “Chemo to Kindness” challenge that inspired others around the world to do acts of good.

    How I Learned to Deal With the Fact That Cancer May Never Go Away

    January 21st 2022

    A woman explains how she grapples with the acceptance that her sister may never enter remission from cancer.

    Louie Anderson Dies After Lymphoma Diagnosis, Tennis Star Chris Evert Shares Ovarian Cancer Diagnosis

    January 21st 2022

    From the death of comedian Louie Anderson after he was hospitalized for cancer treatment to former world No.1 tennis player Chris Evert’s ovarian cancer diagnosis, here’s what’s happening in the cancer landscape this week.

    Enhertu Linked to Sustained Survival Benefit in Gastroesophageal, Gastric Cancer Subset

    January 21st 2022

    The use of Enhertu was associated with a reduction in the risk of death compared with standard chemotherapy in certain patients with gastroesophageal and gastric cancer.

    First-In-Human Clinical Trial of Investigational Therapy for Multiple Advanced Solid Tumors Is Underway

    January 21st 2022

    Researchers plan to enroll 60 patients in the first-in-human phase 1 clinical trial to assess the safety and preliminary clinical activity of an anti-CD39 monoclonal antibody to treat advanced solid tumors.

    Wearable Remote Monitoring Device May Help Patients With Blood Cancers Identify When to Seek Follow-Up Care

    January 20th 2022

    Recent study results showed that the use of a remote monitoring device worn on the upper arm may help patients with blood cancers seek assistance for serious complications while receiving intensive treatments.

    Spare Me the Stories of Cancer Death and Destruction

    January 20th 2022

    When trying to relate to a cancer survivor, do not tell them how someone else died of the disease, writes Michelle Velez.

    Peeling the Onion: Unpacking the Complicated Emotions Experienced as a Cancer Caregiver

    January 20th 2022

    A mother of a breast cancer survivor explains how she pinpoints the reasoning behind why a certain day might be extra difficult emotionally for her and how she deals with it.

    When Diagnosed With Cervical Cancer, Single Mom Turns to Advocacy — for Herself, Her Children and Other Survivors

    January 20th 2022

    In this episode of the “Cancer Horizons” podcast, a cervical cancer survivor and advocate explains how she navigated being given six to 24 months to live as a single mother of three children and no health insurance.

    Amidst New CDC Recommendations, Oncologist Offers Tips on Best Masking Practices for COVID-19 Prevention

    January 19th 2022

    From when to replace masks to addressing a CDC-recommended strategy to improve the effectiveness of surgical masks, Dr. Tatiana M. Prowell of Johns Hopkins Medicine offers masking tips for patients with cancer.

    Survivor Sisters: How Two Different Cancers in Non-Biological Siblings Created an Unbreakable Bond

    January 19th 2022

    A woman living with metastatic breast cancer shares how her relationship with her sister who was adopted from Korea transformed after they both received a cancer diagnosis.

    FDA to Review Libtayo for Frontline Advanced NSCLC

    January 19th 2022

    After promising phase 3 clinical trial results, the FDA will consider Libtayo for approval to treat patients with advanced non-small cell lung cancer, regardless of PD-L1 status.

    Can a Blood Test Detect Lung Cancer in High-Risk Adults?

    January 19th 2022

    A new study to evaluate the accuracy of a blood test for detecting lung cancer in high-risk adults has enrolled its first participant with plans to enroll thousands more.

    Patients With Cancer Strongly Encouraged to Get COVID-19 Boosters to Protect Against Omicron Variant

    January 18th 2022

    A booster dose of the COVID-19 mRNA vaccine may provide patients with cancer with a broader and stronger protection against COVID-19 variants like omicron, according to a cancer researcher at The Ohio State University Comprehensive Cancer Center.

    Why You Should Use Inclusive Language When Talking About Cancer

    January 18th 2022

    A survivor of breast cancer explains what she has learned about inclusive language and how it can empower patients who have been diagnosed with cancer on their healing journey.

    NEXT PAGE
    PREVIOUS PAGE